DK138581C - - Google Patents

Info

Publication number
DK138581C
DK138581C DK543974A DK543974A DK138581C DK 138581 C DK138581 C DK 138581C DK 543974 A DK543974 A DK 543974A DK 543974 A DK543974 A DK 543974A DK 138581 C DK138581 C DK 138581C
Authority
DK
Denmark
Application number
DK543974A
Other languages
Danish (da)
Other versions
DK543974A (US20100268047A1-20101021-C00003.png
DK138581B (da
Inventor
I G S Furminger
M I Brady
Original Assignee
Duncan Flockhart & Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duncan Flockhart & Co Ltd filed Critical Duncan Flockhart & Co Ltd
Publication of DK543974A publication Critical patent/DK543974A/da
Publication of DK138581B publication Critical patent/DK138581B/da
Application granted granted Critical
Publication of DK138581C publication Critical patent/DK138581C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17Newcastle disease virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16251Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18111Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18111Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18151Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK543974AA 1973-10-18 1974-10-17 Fremgangsmåde til fremstilling af en virus-underenhedsvaccine stammende fra et æterfølsomt virus. DK138581B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB48685/73A GB1486557A (en) 1973-10-18 1973-10-18 Process for the preparation of pyrogen-free sub-unit vaccine

Publications (3)

Publication Number Publication Date
DK543974A DK543974A (US20100268047A1-20101021-C00003.png) 1975-06-16
DK138581B DK138581B (da) 1978-10-02
DK138581C true DK138581C (US20100268047A1-20101021-C00003.png) 1979-03-12

Family

ID=10449549

Family Applications (1)

Application Number Title Priority Date Filing Date
DK543974AA DK138581B (da) 1973-10-18 1974-10-17 Fremgangsmåde til fremstilling af en virus-underenhedsvaccine stammende fra et æterfølsomt virus.

Country Status (15)

Country Link
JP (1) JPS5082228A (US20100268047A1-20101021-C00003.png)
AT (1) AT334524B (US20100268047A1-20101021-C00003.png)
BE (1) BE821175A (US20100268047A1-20101021-C00003.png)
CA (1) CA1050886A (US20100268047A1-20101021-C00003.png)
CH (1) CH611518A5 (US20100268047A1-20101021-C00003.png)
DE (1) DE2449530C2 (US20100268047A1-20101021-C00003.png)
DK (1) DK138581B (US20100268047A1-20101021-C00003.png)
FR (1) FR2248054B1 (US20100268047A1-20101021-C00003.png)
GB (1) GB1486557A (US20100268047A1-20101021-C00003.png)
IE (1) IE40187B1 (US20100268047A1-20101021-C00003.png)
IL (1) IL45870A (US20100268047A1-20101021-C00003.png)
NL (1) NL181553C (US20100268047A1-20101021-C00003.png)
NO (1) NO142024C (US20100268047A1-20101021-C00003.png)
SE (1) SE426439B (US20100268047A1-20101021-C00003.png)
ZA (1) ZA746398B (US20100268047A1-20101021-C00003.png)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK276380A (da) * 1979-07-09 1981-01-10 Univ Iowa State Res Found Inc Fremgangsmaade til fremstilling af en vaccine mod infektioes kvaeg-rhinotracheitis
FR2470795A1 (fr) * 1979-12-07 1981-06-12 Pasteur Institut Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus
FR2475572A1 (fr) * 1980-02-11 1981-08-14 Pasteur Institut Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications
FR2483779A1 (fr) 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
JP2004510747A (ja) * 2000-10-02 2004-04-08 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 分割エンベロープウイルス調製物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519400A (en) * 1967-01-25 1970-07-07 Atomic Energy Commission Method of centrifugal separation and recovery of chemical species utilizing a liquid medium

Also Published As

Publication number Publication date
AU7444974A (en) 1976-04-29
IL45870A (en) 1978-03-10
NL181553B (nl) 1987-04-16
DE2449530C2 (de) 1985-08-08
DE2449530A1 (de) 1975-04-30
ZA746398B (en) 1976-06-30
SE426439B (sv) 1983-01-24
IL45870A0 (en) 1974-12-31
NL7413642A (nl) 1975-04-22
CH611518A5 (en) 1979-06-15
GB1486557A (en) 1977-09-21
NO743758L (US20100268047A1-20101021-C00003.png) 1975-05-12
CA1050886A (en) 1979-03-20
IE40187L (en) 1975-04-18
DK543974A (US20100268047A1-20101021-C00003.png) 1975-06-16
FR2248054A1 (US20100268047A1-20101021-C00003.png) 1975-05-16
DK138581B (da) 1978-10-02
FR2248054B1 (US20100268047A1-20101021-C00003.png) 1978-07-28
IE40187B1 (en) 1979-03-28
NO142024B (no) 1980-03-10
ATA835074A (de) 1976-05-15
NO142024C (no) 1980-06-18
BE821175A (fr) 1975-04-17
NL181553C (nl) 1987-09-16
SE7413113L (US20100268047A1-20101021-C00003.png) 1975-04-21
JPS5082228A (US20100268047A1-20101021-C00003.png) 1975-07-03
AT334524B (de) 1976-01-25

Similar Documents

Publication Publication Date Title
AU476761B2 (US20100268047A1-20101021-C00003.png)
AU465372B2 (US20100268047A1-20101021-C00003.png)
AU474593B2 (US20100268047A1-20101021-C00003.png)
AU474511B2 (US20100268047A1-20101021-C00003.png)
AU474838B2 (US20100268047A1-20101021-C00003.png)
AU471343B2 (US20100268047A1-20101021-C00003.png)
AU465453B2 (US20100268047A1-20101021-C00003.png)
AU465434B2 (US20100268047A1-20101021-C00003.png)
AU450229B2 (US20100268047A1-20101021-C00003.png)
AU476714B2 (US20100268047A1-20101021-C00003.png)
FR2248054B1 (US20100268047A1-20101021-C00003.png)
AU472848B2 (US20100268047A1-20101021-C00003.png)
AU466283B2 (US20100268047A1-20101021-C00003.png)
AU476696B2 (US20100268047A1-20101021-C00003.png)
AU477823B2 (US20100268047A1-20101021-C00003.png)
AR196382A1 (US20100268047A1-20101021-C00003.png)
AU477824B2 (US20100268047A1-20101021-C00003.png)
AU447540B2 (US20100268047A1-20101021-C00003.png)
AU461342B2 (US20100268047A1-20101021-C00003.png)
AU471461B2 (US20100268047A1-20101021-C00003.png)
AR197627A1 (US20100268047A1-20101021-C00003.png)
AU476873B1 (US20100268047A1-20101021-C00003.png)
AU1891376A (US20100268047A1-20101021-C00003.png)
AR196212Q (US20100268047A1-20101021-C00003.png)
AU479420A (US20100268047A1-20101021-C00003.png)

Legal Events

Date Code Title Description
PBP Patent lapsed